Prevention of adverse immune reactions involves minimizing exposure to known immunotoxicants and employing risk assessment strategies to evaluate new chemicals. Regulatory agencies set guidelines and permissible exposure limits to protect public health. Furthermore, advances in toxicogenomics can help identify individuals who are genetically susceptible to immunotoxic effects, enabling personalized risk management approaches.
In conclusion, understanding adverse immune reactions in the context of toxicology is vital for safeguarding human health. As research progresses, our ability to predict and mitigate these reactions through improved testing methods and regulatory measures continues to enhance our capacity to manage the risks associated with chemical exposures.
